Premium Nahrungsergänzungsmittel | artgerecht

DOG1 – Biomarker for GIST Tumors Explained

DOG1 is a diagnostic biomarker strongly expressed in gastrointestinal stromal tumors (GIST) and widely used in pathology for precise tumor identification and classification.

Regular tips about health Regular tips about health

Things worth knowing about "DOG1"

DOG1 is a diagnostic biomarker strongly expressed in gastrointestinal stromal tumors (GIST) and widely used in pathology for precise tumor identification and classification.

What is DOG1?

DOG1 (Discovered on GIST 1, also known as ANO1 or TMEM16A) is a transmembrane protein that functions as a calcium-activated chloride channel. It was first identified as a highly specific marker for gastrointestinal stromal tumors (GIST) and has since become an indispensable tool in immunohistochemical diagnostics in pathology.

Biological Function

DOG1 encodes a calcium-activated chloride ion channel found in various tissues throughout the body. It plays a role in cell volume regulation, secretory functions of epithelial cells, and cell proliferation and migration. In healthy tissue, DOG1 is notably expressed in the interstitial cells of Cajal (ICC), the pacemaker cells of the gastrointestinal tract from which GISTs frequently originate.

DOG1 as a Diagnostic Marker

In clinical pathology, DOG1 is used as an immunohistochemical marker to distinguish GIST tumors from other mesenchymal tumors of the gastrointestinal tract. The marker demonstrates high diagnostic sensitivity and specificity:

Sensitivity: DOG1 is positive in approximately 94–98% of all GIST cases, including KIT-negative and PDGFRA-mutated tumors.
Specificity: DOG1 is negative in most non-GIST tumors, significantly facilitating differential diagnosis.
DOG1 is especially valuable for diagnosing GISTs that lack a KIT mutation (CD117), as these tumors often go undetected when CD117 alone is used.

Clinical Significance in GIST

Gastrointestinal stromal tumors are the most common mesenchymal tumors of the gastrointestinal tract. Accurate diagnosis is critical because GISTs respond to targeted therapies with tyrosine kinase inhibitors such as imatinib. A positive DOG1 result in immunohistochemical staining, combined with clinical and morphological findings, confirms the GIST diagnosis and enables appropriate treatment to be initiated.

DOG1 in Immunohistochemistry

Immunohistochemical testing for DOG1 is performed on tissue samples (biopsies or surgical specimens) that are fixed, embedded, and stained with specific antibodies targeting the DOG1 protein. A positive DOG1 staining appears as a characteristic pattern within tumor cells and is evaluated by a pathologist. Commonly used antibodies in clinical practice include K9 and SP31.

DOG1 Expression in Other Tumor Entities

Beyond GIST, DOG1 expression has also been reported in other tumor types, including:

Salivary gland tumors (e.g., mucinous adenocarcinomas)
Certain breast and lung carcinomas
Synovial sarcomas (in rare cases)

These expression patterns are currently under scientific investigation and may gain further diagnostic or therapeutic relevance in the future.

References

Liegl B et al. – Monoclonal antibody DOG1.1 shows higher sensitivity than KIT in the diagnosis of gastrointestinal stromal tumors, including unusual subtypes. American Journal of Surgical Pathology, 2009.
West RB et al. – The novel marker, DOG1, is expressed ubiquitously in gastrointestinal stromal tumors irrespective of KIT or PDGFRA mutation status. American Journal of Pathology, 2004.
Miettinen M, Lasota J – Gastrointestinal stromal tumors: review on morphology, molecular pathology, prognosis, and differential diagnosis. Archives of Pathology & Laboratory Medicine, 2006.

Building Blocks for a Healthy Life

As an integrated manufacturer, we develop & produce evidence-based, patented, and non-patented formulations. We work exclusively with plant and natural extracts according to the strictest purity & quality standards.
The combination of science & modern technology with the laws of nature creates solutions consistently tailored to humans – for the highest good: health.